62 related articles for article (PubMed ID: 31016451)
1. Recent trends in incidence, mortality, survival, and treatment of upper tract urothelial carcinoma.
Ma Z; Yi Y; Qiu Z
Fr J Urol; 2024 Mar; 34(2):102573. PubMed ID: 38330829
[TBL] [Abstract][Full Text] [Related]
2. Unveiling the challenges of UTUC biopsies and cytology: insights from a global real-world practice study.
Baard J; Cormio L; Dasgupta R; Maruzzi D; Rais-Bahrami S; Serrano A; Geavlete B; Giannakopoulos S; de la Rosette J; Laguna P
World J Urol; 2024 Mar; 42(1):177. PubMed ID: 38507109
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous resection of upper tract urothelial cell carcinoma: When, how, and is it safe?
Strijbos WE; van der Heij B
Asian J Urol; 2016 Jul; 3(3):134-141. PubMed ID: 29264181
[TBL] [Abstract][Full Text] [Related]
4. Immune checkpoint inhibitors in high-grade upper tract urothelial carcinoma: Paradigm shift emphasizing organ preservation.
Khalil M; Fishman A; Komorowski A; Franco I; Grasso M
BJUI Compass; 2024 May; 5(5):490-496. PubMed ID: 38751949
[TBL] [Abstract][Full Text] [Related]
5. Diagnosing upper tract urothelial carcinoma: A review of the role of diagnostic ureteroscopy and novel developments over last two decades.
Gravestock P; Cullum D; Somani B; Veeratterapillay R
Asian J Urol; 2024 Apr; 11(2):242-252. PubMed ID: 38680592
[TBL] [Abstract][Full Text] [Related]
6. Consultation on UTUC II Stockholm 2022: diagnostic and prognostic methods-what's around the corner?
Grahn A; Coleman JA; Eriksson Y; Gabrielsson S; Madsen JS; Tham E; Thomas K; Turney B; Uhlén P; Vollmer T; Zieger K; Osther PJS; Brehmer M
World J Urol; 2023 Dec; 41(12):3405-3411. PubMed ID: 37725130
[TBL] [Abstract][Full Text] [Related]
7. Consultation on UTUC II Stockholm 2022: diagnostics, prognostication, and follow-up-where are we today?
Sydén F; Baard J; Bultitude M; Keeley FX; Rouprêt M; Thomas K; Axelsson TA; Jaremko G; Jung H; Malm C; Proietti S; Osther PJS; Brehmer M
World J Urol; 2023 Dec; 41(12):3395-3403. PubMed ID: 37540248
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of perirenal fat stranding on oncologic outcomes in ureteral urothelial carcinoma.
Chung JW; Lee JN; Park KM; Byeon KH; Cheon H; Ha YS; Choi SH; Kim BS; Kim TH; Yoo ES; Kwon TG; Kim HT
Investig Clin Urol; 2021 Jan; 62(1):23-31. PubMed ID: 33314805
[TBL] [Abstract][Full Text] [Related]
9. Consultation on UTUC Stockholm 2018.
Brehmer M; Osther P
World J Urol; 2019 Nov; 37(11):2269-2270. PubMed ID: 31494723
[No Abstract] [Full Text] [Related]
10. Volumetric imaging: a potential tool to stage upper tract urothelial carcinoma.
Grahn A; Tanaka N; Uhlén P; Brehmer M
World J Urol; 2019 Nov; 37(11):2297-2302. PubMed ID: 30820651
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Analysis of Diagnostic Ureteroscopic Biopsy for Intravesical Recurrence of Upper Urinary Tract Urothelial Carcinoma.
Chen H; Wang M; Weng T; Wei Y; Yang L; Ren K; Tang Z; Gou X
Urol Int; 2022; 106(2):186-194. PubMed ID: 34492655
[TBL] [Abstract][Full Text] [Related]
12. Grading of urothelial carcinoma of the upper urinary tract according to the World Health Organization/International Society of Urological Pathology classification from 2004 is a valuable tool when considering whether a patient is suitable for endoscopic treatment.
Almås B; Halvorsen OJ; Gjengstø P; Ulvik Ø; Beisland C
Scand J Urol; 2016 Aug; 50(4):298-304. PubMed ID: 26926878
[TBL] [Abstract][Full Text] [Related]
13. Impact of tumour size on prognosis of upper urinary tract urothelial carcinoma after radical nephroureterectomy: a multi-institutional analysis of 795 cases.
Shibing Y; Liangren L; Qiang W; Hong L; Turun S; Junhao L; Lu Y; Zhengyong Y; Yonghao J; Guangqing F; Yunxiang L; Dehong C
BJU Int; 2016 Dec; 118(6):902-910. PubMed ID: 26935344
[TBL] [Abstract][Full Text] [Related]
14. Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review.
Cutress ML; Stewart GD; Zakikhani P; Phipps S; Thomas BG; Tolley DA
BJU Int; 2012 Sep; 110(5):614-28. PubMed ID: 22471401
[TBL] [Abstract][Full Text] [Related]
15. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.
Seisen T; Peyronnet B; Dominguez-Escrig JL; Bruins HM; Yuan CY; Babjuk M; Böhle A; Burger M; Compérat EM; Cowan NC; Kaasinen E; Palou J; van Rhijn BW; Sylvester RJ; Zigeuner R; Shariat SF; Rouprêt M
Eur Urol; 2016 Dec; 70(6):1052-1068. PubMed ID: 27477528
[TBL] [Abstract][Full Text] [Related]
16. Predicting invasiveness and disease-specific survival in upper tract urothelial carcinoma: identifying relevant clinical tumour characteristics.
Malm C; Grahn A; Jaremko G; Tribukait B; Brehmer M
World J Urol; 2019 Nov; 37(11):2335-2342. PubMed ID: 31016451
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
